FDA advisory committee
FDA Advisory Committee Supports Nirsevimab to Prevent RSV in Infants
The FDA Antimicrobial Drugs Advisory Committee endorsed the safety and efficacy of an experimental ...
JUNE 9, 2023
VRBPAC Recommends Ferring’s Biotherapeutic to Reduce Recurrent CDI
The FDA Advisory Committee, VRBPAC issued a positive vote recommending Ferring’s biotherapeutic to reduce ...
SEPTEMBER 23, 2022
FDA Grants New Indication for Descovy for PrEP
Descovy for PrEP is indicated to reduce the risk for sexually acquired HIV-1 infection in adults and adolescents ...
OCTOBER 3, 2019
Tafenoquine Gets FDA Advisory Committee Nod for Approval
The FDA Antimicrobial Drugs Advisory Committee today voted to recommended approval of GSK's tafenoquine for the ...
JULY 12, 2018
FDA Advisory Committee Gives Solithromycin Mixed Review
The committee was concerned about hepatic toxicity, as well as providers using the agent outside its indication for ...
NOVEMBER 4, 2016
